To explore whether the FXR/SHP signaling pathway mediated the beneficial effect of ivermectin against hepatic fibrosis, we assessed the hepatic expression of SHP in CCl4-treated mice and found that the CCl4 injection significantly reduced the SHP mRNA expression. Here, NR0B2 is linked to Hepatic fibrosis.